Reactions 1704, p152 - 2 Jun 2018 Folliculitis decalvans and bacterial superinfection: case report A 66-year-old woman developed folliculitis decalvans and bacterial superinfection during treatment with erlotinib for metastatic pulmonary adenocarcinoma. Subsequently, she died. The woman, who had been diagnosed with metastatic pulmonary adenocarcinoma, started receiving erlotinib 150 mg/day [route not stated]. She presented with grade I papulopustular rash, which progressed to grade II rash during the next three weeks. The woman was treated with topical corticosteroids along with doxycycline, but response was poor. Her erlotinib dose was decreased to 100 mg/day, which controlled the papulopustular lesions. Six months later, she had a follow-up visit at dermatologist for her crusted scalp lesions. A physical examination showed generalised swelling all over the scalp over a confluent and malodorous pustular base. She was diagnosed with bacterial superinfection secondary to erlotinib. The sample of the exudate was taken for culture and doxycycline was initiated. In the culture, Methicillin-sensitive Staphylococcus aureus was isolated. Her treatment was planned according to the antibiogram. But, her condition deteriorated over the following days, with increased hair loss, leaving deepithelialised alopecic plaques with a scar-like appearance alternating with purulent and macerated areas. A diagnosis of folliculitis decalvans due to bacterial superinfection secondary to erlotinib was made. A week later, she died of acute pulmonary thromboembolism. Author comment: "In conclusion, we present a case of bacterial superinfection associated with erlotinib that manifested as folliculitis decalvans, a complication that has received little attention in the literature". Sahuquillo-Torralba A, et al. Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib. Actas Dermo-Sifiliograficas 109: 363-364, No. 4, May 2018. Available from: URL: http://doi.org/10.1016/ j.adengl.2018.03.007 - Spain 803323229 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera